HENRY SCHEIN INC (HSIC)
US8064071025 - Common Stock
HSIC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 113 industry peers in the Health Care Providers & Services industry. HSIC has an average financial health and profitability rating. HSIC has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year HSIC was profitable.
HSIC had a positive operating cash flow in the past year.
HSIC had positive earnings in each of the past 5 years.
Each year in the past 5 years HSIC had a positive operating cash flow.
1.2 Ratios
HSIC has a Return On Assets of 2.96%. This is in the better half of the industry: HSIC outperforms 71.68% of its industry peers.
Looking at the Return On Equity, with a value of 8.96%, HSIC is in the better half of the industry, outperforming 76.11% of the companies in the same industry.
The Return On Invested Capital of HSIC (5.64%) is better than 67.26% of its industry peers.
HSIC had an Average Return On Invested Capital over the past 3 years of 9.29%. This is in line with the industry average of 8.10%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.96% | ||
| ROE | 8.96% | ||
| ROIC | 5.64% |
ROA(3y)5.88%
ROA(5y)6.51%
ROE(3y)15.14%
ROE(5y)16.13%
ROIC(3y)9.29%
ROIC(5y)9.35%
1.3 Margins
With a decent Profit Margin value of 2.51%, HSIC is doing good in the industry, outperforming 70.80% of the companies in the same industry.
In the last couple of years the Profit Margin of HSIC has declined.
HSIC has a Operating Margin of 4.86%. This is in the better half of the industry: HSIC outperforms 63.72% of its industry peers.
HSIC's Operating Margin has declined in the last couple of years.
HSIC has a Gross Margin (31.59%) which is comparable to the rest of the industry.
HSIC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.86% | ||
| PM (TTM) | 2.51% | ||
| GM | 31.59% |
OM growth 3Y1.22%
OM growth 5Y-4.64%
PM growth 3Y-5.48%
PM growth 5Y-9.94%
GM growth 3Y4.01%
GM growth 5Y0.25%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HSIC is still creating some value.
HSIC has less shares outstanding than it did 1 year ago.
The number of shares outstanding for HSIC has been reduced compared to 5 years ago.
Compared to 1 year ago, HSIC has a worse debt to assets ratio.
2.2 Solvency
HSIC has an Altman-Z score of 2.78. This is not the best score and indicates that HSIC is in the grey zone with still only limited risk for bankruptcy at the moment.
HSIC has a Altman-Z score of 2.78. This is in the better half of the industry: HSIC outperforms 70.80% of its industry peers.
The Debt to FCF ratio of HSIC is 6.79, which is on the high side as it means it would take HSIC, 6.79 years of fcf income to pay off all of its debts.
HSIC has a Debt to FCF ratio of 6.79. This is in the better half of the industry: HSIC outperforms 73.45% of its industry peers.
A Debt/Equity ratio of 0.73 indicates that HSIC is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.73, HSIC is in line with its industry, outperforming 46.02% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 6.79 | ||
| Altman-Z | 2.78 |
ROIC/WACC0.69
WACC8.18%
2.3 Liquidity
HSIC has a Current Ratio of 1.42. This is a normal value and indicates that HSIC is financially healthy and should not expect problems in meeting its short term obligations.
HSIC has a Current ratio of 1.42. This is comparable to the rest of the industry: HSIC outperforms 47.79% of its industry peers.
HSIC has a Quick Ratio of 1.42. This is a bad value and indicates that HSIC is not financially healthy enough and could expect problems in meeting its short term obligations.
HSIC has a Quick ratio of 0.82. This is in the lower half of the industry: HSIC underperforms 75.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.42 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
The earnings per share for HSIC have decreased strongly by -16.63% in the last year.
The Earnings Per Share has been growing slightly by 1.68% on average over the past years.
The Revenue has decreased by -1.53% in the past year.
HSIC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.55% yearly.
EPS 1Y (TTM)-16.63%
EPS 3Y14.86%
EPS 5Y1.68%
EPS Q2Q%-7.58%
Revenue 1Y (TTM)-1.53%
Revenue growth 3Y6.84%
Revenue growth 5Y5.55%
Sales Q2Q%0.38%
3.2 Future
Based on estimates for the next years, HSIC will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.64% on average per year.
Based on estimates for the next years, HSIC will show a small growth in Revenue. The Revenue will grow by 6.65% on average per year.
EPS Next Y8.13%
EPS Next 2Y8.58%
EPS Next 3Y8.74%
EPS Next 5Y10.64%
Revenue Next Year3.87%
Revenue Next 2Y3.86%
Revenue Next 3Y3.94%
Revenue Next 5Y6.65%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 17.52, which indicates a rather expensive current valuation of HSIC.
Based on the Price/Earnings ratio, HSIC is valued a bit cheaper than the industry average as 77.88% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of HSIC to the average of the S&P500 Index (28.65), we can say HSIC is valued slightly cheaper.
The Price/Forward Earnings ratio is 13.90, which indicates a correct valuation of HSIC.
Based on the Price/Forward Earnings ratio, HSIC is valued cheaper than 81.42% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.56. HSIC is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.52 | ||
| Fwd PE | 13.9 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, HSIC is valued a bit cheaper than the industry average as 69.03% of the companies are valued more expensively.
HSIC's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. HSIC is cheaper than 74.34% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.52 | ||
| EV/EBITDA | 12.35 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HSIC does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of HSIC may justify a higher PE ratio.
PEG (NY)2.16
PEG (5Y)10.42
EPS Next 2Y8.58%
EPS Next 3Y8.74%
5. Dividend
5.1 Amount
No dividends for HSIC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
HENRY SCHEIN INC
NASDAQ:HSIC (11/21/2024, 4:20:00 PM)
After market: 73.77 0 (0%)73.77
+0.04 (+0.05%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap9.20B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.52 | ||
| Fwd PE | 13.9 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.16
PEG (5Y)10.42
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.96% | ||
| ROE | 8.96% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 4.86% | ||
| PM (TTM) | 2.51% | ||
| GM | 31.59% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.18
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.42 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-16.63%
EPS 3Y14.86%
EPS 5Y
EPS Q2Q%
EPS Next Y8.13%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.53%
Revenue growth 3Y6.84%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y